ftInvstr
RPGLIFE · Healthcare ₹2596.8 +0.69% Mkt Cap ₹4312 Cr

RPGLIFE

Healthcare Drug Manufacturers - Specialty & Generic
₹2596.8
+0.69% today · 30d -4.41%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for RPGLIFE. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹196 Cr
+15.85% YoY
NET PROFIT
₹31 Cr
+17.0% YoY
OPM
23.95%
+0.58pp YoY
EPS
₹18.6
PE 38.89
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-0.2% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
RPGLIFE38.89—
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
59
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation FAIR 40
Growth MUTED 30
Profitability HIGH 75
Technicals WEAK 45
Risk LOW 90
Key Stats
TTM PE
38.89
P/B
5.91
52W HIGH
₹3127.8
OFF HIGH
-16.98%
DIV YIELD
0.92%
MKT CAP
₹4312 Cr
◉ Active Signals
MACDBearish-19.3983
RSI(14)Neutral43.73
Street Consensus
1 analyst
₹3205.0
mean target
Low ₹3205.0Now ₹2596.8High ₹3205.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold RPGLIFE and at what entry.

Sign up freeSign in